// App-Quantinova.ai

PB0410 : A novel Interaction between Coagulation Factor XI and its Activated Form, FXIa, with the Complement Protein Properdin

Researchers

Presenter

  • S.L. Heal

Principal Investigators

  • L.J. Hardy

  • C. Wilson

  • M. Ali

  • R. Arins

  • R. Foster

  • H. Philippou

Medical Centers

  • University of Leeds, Leeds Institute of Cardiovascular and Metabolic Medicine, Leeds, United Kingdom

  • University of Leeds, School of Chemistry, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Dextran sulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved